US Patent Issued to Emory University on Aug. 5 for "Hyaluronic acid nanoparticles comprising NADPH oxidases inhibitors and uses in treating cancer" (Georgia Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,117, issued on Aug. 5, was assigned to Emory University (Atlanta).

"Hyaluronic acid nanoparticles comprising NADPH oxidases inhibitors and uses in treating cancer" was invented by Lily Yang (Atlanta) and Lei Zhu (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to hyaluronic acid nanoparticles containing an anticancer agent such as a NADPH oxidase (NOX) inhibitor for targeted delivery to cancerous cells or tumors. In certain embodiments, the nanoparticles are made up of hyaluronic acid conjugated to hydrophobic moieties. In certain embodiments, the hydrophobic moieties are steroid based compounds, such as 5beta-cholanic ...